Clovis Oncology, Inc. Recorded Big Gain

Tue, Jun 21, 2022 at 08:21 PM
Clovis Oncology, Inc. Recorded Big Gain

Clovis Oncology, Inc. (CLVS:NASDAQ) soared at $1.64, a gain of 39%. On Tue, Jun 21, 2022, CLVS:NASDAQ touched a New 2-Week High of $1.64. The stock got featured on our News Catalysts scanner on Thu, Jun 16, 2022 at 07:32 PM in the 'BIOTECH' category. From Tue, Jun 07, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days

The stock spiked on Tue, Jun 21, 2022 at $2.4 with a volume of 109M+.

About Clovis Oncology, Inc. (CLVS:NASDAQ)

Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.